ASTH vs HUM
ASTH: Astrana Health is a physician-centric, technology-enabled platform that manages care and operations for value-based healthcare providers serving Medicare and Medicaid patients. HUM: A prominent managed care organization and provider of Medicare Advantage insurance plans.
Side-by-side fundamentals
| Metric | ASTH | HUM | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $38.58 | $427.38 | |
| Market cap | $2.2B | $51.3B | |
| P/E as of 2026-10-20 | 47.05 | 45.61 | HUM lower |
| Net margin FY2025, SEC XBRL | +0.7% | +0.9% | HUM higher |
| Operating margin FY2025, SEC XBRL | +2.5% | +2.1% | ASTH higher |
| ROE FY2025, SEC XBRL | +2.8% | +6.7% | HUM higher |
| ROA FY2025, SEC XBRL | +1.0% | +2.4% | HUM higher |
| Debt / equity | 1.13 | 0.75 | HUM lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +56.4% | +10.1% | ASTH higher |
| Revenue CAGR (3y) SEC XBRL | +40.6% | +11.8% | ASTH higher |
| Dividend yield as of 2026-09-03 | n/a | +0.9% | |
| Dividend streak (yrs) SEC XBRL | n/a | 15 | |
| Beta as of 2026-09-03 | 0.64 | 0.48 | |
| 1-year return as of 2026-10-20 close | +16.9% | +50.5% | HUM higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.